Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy
- PMID: 15987957
- DOI: 10.1093/glycob/cwi100
Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy
Abstract
Hereditary inclusion body myopathy (HIBM) is an autosomal recessive neuromuscular disorder associated with mutations in uridine diphosphate (UDP)-N-acetylglucosamine (GlcNAc) 2-epimerase (GNE)/N-acetylmannosamine (ManNAc) kinase (MNK), the bifunctional and rate-limiting enzyme of sialic acid biosynthesis. We developed individual GNE and MNK enzymatic assays and determined reduced activities in cultured fibroblasts of patients, with HIBM harboring missense mutations in either or both the GNE and MNK enzymatic domains. To assess the effects of individual mutations on enzyme activity, normal and mutated GNE/MNK enzymatic domains were synthesized in a cell-free in vitro transcription-translation system and subjected to the GNE and MNK enzymatic assays. This cell-free system was validated for both GNE and MNK activities, and it revealed that mutations in one enzymatic domain (in GNE, G135V, V216A, and R246W; in MNK, A631V, M712T) affected not only that domain's enzyme activity, but also the activity of the other domain. Moreover, studies of the residual enzyme activity associated with specific mutations revealed a discrepancy between the fibroblasts and the cell-free systems. Fibroblasts exhibited higher residual activities of both GNE and MNK than the cell-free system. These findings add complexity to the tightly regulated system of sialic acid biosynthesis. This cell-free approach can be applied to other glycosylation pathway enzymes that are difficult to evaluate in whole cells because their substrate specificities overlap with those of ancillary enzymes.
Similar articles
-
Influence of UDP-GlcNAc 2-epimerase/ManNAc kinase mutant proteins on hereditary inclusion body myopathy.Biochemistry. 2006 Mar 7;45(9):2968-77. doi: 10.1021/bi0522504. Biochemistry. 2006. PMID: 16503651
-
The homozygous M712T mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase results in reduced enzyme activities but not in altered overall cellular sialylation in hereditary inclusion body myopathy.FEBS Lett. 2004 May 21;566(1-3):105-9. doi: 10.1016/j.febslet.2004.04.013. FEBS Lett. 2004. PMID: 15147877
-
The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy.Nat Genet. 2001 Sep;29(1):83-7. doi: 10.1038/ng718. Nat Genet. 2001. PMID: 11528398
-
Regulation and pathophysiological implications of UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE) as the key enzyme of sialic acid biosynthesis.Biol Chem. 2009 Jul;390(7):591-9. doi: 10.1515/BC.2009.073. Biol Chem. 2009. PMID: 19426133 Review.
-
[Molecular pathomechanism of distal myopathy with rimmed vacuoles].Rinsho Shinkeigaku. 2005 Nov;45(11):943-5. Rinsho Shinkeigaku. 2005. PMID: 16447769 Review. Japanese.
Cited by
-
GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges.Neurotherapeutics. 2018 Oct;15(4):900-914. doi: 10.1007/s13311-018-0671-y. Neurotherapeutics. 2018. PMID: 30338442 Free PMC article. Review.
-
Role of UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase (GNE) in β1-integrin-mediated cell adhesion.Mol Neurobiol. 2014 Oct;50(2):257-73. doi: 10.1007/s12035-013-8604-6. Epub 2014 Jan 29. Mol Neurobiol. 2014. PMID: 24474513
-
Two recurrent mutations are associated with GNE myopathy in the North of Britain.J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1359-65. doi: 10.1136/jnnp-2013-306314. Epub 2014 Apr 2. J Neurol Neurosurg Psychiatry. 2014. PMID: 24695763 Free PMC article.
-
Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine.J Clin Invest. 2007 Jun;117(6):1585-94. doi: 10.1172/JCI30954. J Clin Invest. 2007. PMID: 17549255 Free PMC article.
-
Sialic acid utilization.Adv Nutr. 2012 May 1;3(3):392S-7S. doi: 10.3945/an.111.001479. Adv Nutr. 2012. PMID: 22585917 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources